In Conversation with Dr Daniel Chen and Dr Greg Thurber
As anticipation builds for the 17th World ADC San Diego Summit, two of this year's speakers, Dr. Daniel Chen and Dr. Greg Thurber, joined The Oncology Insights Podcast to discuss the latest advancements shaping the ADC landscape.
During the episode, they explore the evolving science of antibody-drug conjugates (ADCs), including how ADCs combine targeted antibody delivery with potent payloads, the importance of linker design and tumor distribution, and the growing understanding of how ADCs interact with the immune system.
The discussion also looks ahead to emerging innovations, including dual-payload ADCs, novel antibody formats, combination strategies, and the potential role of AI in future drug development. Together, these advances could help expand treatment options, improve durability of response, and enhance outcomes for patients with cancer.
As the ADC field continues to evolve at an unprecedented pace, this conversation provides valuable insight into the opportunities and challenges driving the next generation of ADC therapies.